Page 32 - Read Online

Page 20 of 22 Ballestri et al. Metab Target Organ Damage 2023;3:1 https://dx.doi.org/10.20517/mtod.2022.23

53. Oeda S, Takahashi H, Imajo K, et al. Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with
significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: comparison between M and XL probes.
Hepatol Res 2020;50:831-9. DOI PubMed
54. Kim BK, Tamaki N, Imajo K, et al. Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or
higher among patients with NAFLD. J Hepatol 2022;77:1482-90. DOI
55. Ng CH, Lim WH, Hui Lim GE, et al. Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and
meta-analysis. Clin Gastroenterol Hepatol ;2022:S1542-3565(22)00439. DOI PubMed
56. Reddy YK, Marella HK, Jiang Y, et al. Natural history of non-alcoholic fatty liver disease: a study with paired liver biopsies. J Clin
Exp Hepatol 2020;10:245-54. DOI PubMed PMC
57. Perazzo H, Munteanu M, Ngo Y, et al. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and
dyslipidaemia. Aliment Pharmacol Ther 2014;40:1081-93. DOI PubMed
58. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with
nonalcoholic fatty liver disease in the United States. Hepatology 2013;57:1357-65. DOI PubMed PMC
59. Song DS, Chang UI, Kang SG, Song SW, Yang JM. Noninvasive serum fibrosis markers are associated with coronary artery
calcification in patients with nonalcoholic fatty liver disease. Gut Liver 2019;13:658-68. DOI PubMed PMC
60. Schonmann Y, Yeshua H, Bentov I, Zelber-Sagi S. Liver fibrosis marker is an independent predictor of cardiovascular morbidity and
mortality in the general population. Dig Liver Dis 2021;53:79-85. DOI PubMed
61. Han E, Lee YH, Lee JS, et al. Fibrotic burden determines cardiovascular risk among subjects with metabolic dysfunction-associated
fatty liver disease. Gut Liver 2022;16:786-97. DOI PubMed PMC
62. Chen Q, Li Q, Li D, et al. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery
disease. Atherosclerosis 2020;299:45-52. DOI PubMed
63. Baratta F, Pastori D, Angelico F, et al. Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular
events in a prospective study. Clin Gastroenterol Hepatol 2020;18:2324-2331.e4. DOI PubMed
64. Lee J, Kim HS, Cho YK, et al. Association between noninvasive assessment of liver fibrosis and coronary artery calcification
progression in patients with nonalcoholic fatty liver disease. Sci Rep 2020;10:18323. DOI PubMed PMC
65. Liu HH, Cao YX, Jin JL, et al. Liver fibrosis scoring systems as novel tools for predicting cardiovascular outcomes in patients
following elective percutaneous coronary intervention. J Am Heart Assoc 2021;10:e018869. DOI PubMed PMC
66. Peters AE, Pandey A, Ayers C, et al. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with
preserved ejection fraction: findings from TOPCAT. ESC Heart Fail 2021;8:842-8. DOI PubMed PMC
67. Parikh NS, Koh I, VanWagner LB, Elkind MSV, Zakai NA, Cushman M. Liver fibrosis is associated with ischemic stroke risk in
women but not men: the REGARDS study. J Stroke Cerebrovasc Dis 2021;30:105788. DOI
68. Oh TJ, Kim K, Moon JH, Choi SH, Cho NH, Jang HC. Liver fibrosis indices for the prediction of mortality in korean subjects: a 16-
year prospective cohort study. J Endocr Soc 2021;5:bvab123. DOI PubMed PMC
69. Delgado GE, Kleber ME, Moissl AP, et al. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in
patients with medium-to-high cardiovascular risk. Am J Physiol Gastrointest Liver Physiol 2021;321:G252-61. DOI
70. Tamaki N, Kurosaki M, Takahashi Y, et al. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. J
Gastroenterol Hepatol 2021;36:2960-6. DOI PubMed
71. Akuta N, Kawamura Y, Arase Y, et al. PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients
with histopathologically-confirmed NAFLD. BMC Gastroenterol 2021;21:434. DOI PubMed PMC
72. Jin JL, Zhang HW, Cao YX, et al. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary
artery disease. Hepatol Int 2021;15:413-23. DOI PubMed
73. Zupo R, Castellana F, De Nucci S, et al. Liver fibrosis and 8-year all-cause mortality trajectories in the aging cohort of the salus in
apulia study. Biomedicines 2021;9:1617. DOI PubMed PMC
74. Zupo R, Castellana F, Donghia R, et al. Liver frailty and all-cause mortality in the older participants of the Salus in Apulia study.
Geroscience 2022;44:835-45. DOI PubMed PMC
75. Vieira Barbosa J, Milligan S, Frick A, et al. Fibrosis-4 index can independently predict major adverse cardiovascular events in
nonalcoholic fatty liver disease. Am J Gastroenterol 2022;117:453-61. DOI PubMed
76. Ferraioli G, Wong VW, Castera L, et al. Liver ultrasound elastography: an update to the world federation for ultrasound in medicine
and biology guidelines and recommendations. Ultrasound Med Biol 2018;44:2419-40. DOI PubMed
77. Ballestri S, Nascimbeni F, Lugari S, Lonardo A, Francica G. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert
Rev Gastroenterol Hepatol 2019;13:667-81. DOI PubMed
78. Ajmera V, Loomba R. Imaging biomarkers of NAFLD, NASH, and fibrosis. Mol Metab 2021;50:101167. DOI PubMed PMC
79. Lee MS, Bae JM, Joo SK, Woo H, Lee DH, Jung YJ, et al. Prospective comparison among transient elastography, supersonic shear
imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease. PLoS One 2017;12:e0188321. DOI
80. Honda Y, Yoneda M, Imajo K, Nakajima A. Elastography techniques for the assessment of liver fibrosis in non-alcoholic fatty liver
disease. Int J Mol Sci 2020;21:4039. DOI PubMed PMC
81. Conti CB, Cavalcoli F, Fraquelli M, Conte D, Massironi S. Ultrasound elastographic techniques in focal liver lesions. World J
Gastroenterol 2016;22:2647-56. DOI PubMed PMC
82. Liu H, Fu J, Hong R, Liu L, Li F. Acoustic radiation force impulse elastography for the non-invasive evaluation of hepatic fibrosis in